What were the main drivers of revenue growth in the first quarter of 2015?

Revenue growth was primarily driven by a 11.1% increase in net revenues, with the Pharmacy Services segment seeing an 18.2% rise due to specialty pharmacy expansion and higher pharmacy network claims. The Retail Pharmacy segment contributed with a 2.9% revenue increase, supported by growth in pharmacy same-store sales and new store openings.

How did the company's share repurchase program progress during the quarter?

CVS Health actively repurchased shares, spending $2.0 billion on stock buybacks during the first quarter of 2015. This was executed through an accelerated share repurchase agreement, reflecting a strong commitment to returning capital to shareholders.

What challenges did CVS Health face during this period?

The company highlighted ongoing challenges related to price compression from increased generic drug dispensing rates and reimbursement pressure from third-party payors. Additionally, the Retail Pharmacy segment experienced a decrease in front-store same-store sales, partly due to the decision to stop selling tobacco products.

What is the outlook for the Pharmacy Services segment?

The Pharmacy Services segment showed significant growth, with increased mail choice and pharmacy network claims processed. Management expects continued increases in generic dispensing rates, though potentially at a slower pace, and anticipates ongoing competitive pressures and efforts by payors to manage costs, which could impact margins.

CVS 10-Q Quarterly Report Q1 FY2015 — Revenue, Net Income, EPS

Summary

CVS Health Corporation reported solid financial results for the first quarter of 2015, demonstrating continued growth across its key business segments. Net revenues increased by 11.1% year-over-year, driven by robust performance in both the Pharmacy Services and Retail Pharmacy segments. The Pharmacy Services segment benefited from growth in specialty pharmacy and an increase in pharmacy network claims, while the Retail Pharmacy segment saw improvements in pharmacy same-store sales. Profitability metrics showed positive trends, with operating profit increasing by 5.4%. The company also made significant strides in returning capital to shareholders, repurchasing $2.0 billion in common stock during the quarter, underscoring a commitment to enhancing shareholder value. While facing pressures from generic drug price compression and reimbursement rate challenges, CVS Health's diversified business model and strategic initiatives appear to be effectively navigating these headwinds.

Financial Highlights

54 data points

Beta

Revenue

$36.33B

0.2% Gross Margin

Net Income

$1.22B

0.0% Net Margin

EPS (Diluted)

$1.07

Total Assets

$73.93B

Cash & Equivalents

$1.52B

Free Cash Flow

$1.56B

Financial Statements

Beta

Revenue	$36.33B
Cost of Revenue	$30.17B
Gross Profit	$6.16B
Operating Expenses	$4.03B
Operating Income	$2.13B
Interest Expense	$137.00M
Net Income	$1.22B
EPS (Basic)	$1.08
EPS (Diluted)	$1.07
Shares Outstanding (Basic)	1.13B
Shares Outstanding (Diluted)	1.14B

Key Highlights

1Net revenues grew 11.1% to $36.3 billion compared to the prior year's first quarter.
2Operating profit increased by 5.4% to $2.13 billion.
3Diluted earnings per share rose to $1.07, up from $0.95 in the prior year's quarter.
4The company repurchased $2.0 billion of its common stock in the first quarter of 2015.
5Pharmacy Services segment revenues increased by 18.2% year-over-year, driven by specialty pharmacy growth and increased network claims.
6Retail Pharmacy segment revenues increased by 2.9%, with pharmacy same-store sales growing 4.2%.
7The generic dispensing rate continued to increase across both segments, reaching 83.5% in Pharmacy Services and 84.4% in Retail Pharmacy.

CVS HEALTH Corp Quarterly Report for Q1 Ended Mar 31, 2015

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions